| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |